GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, and Rybelsus® have shown significant weight loss results. Patients have lost up to 15-22% of their body weight over a year. Now, with sublingual GLP-1 alternatives like Semaglutide and Tirzepatide, those seeking a needle-free solution can achieve similar weight loss benefits.

Injectable GLP-1 medications like Ozempic®, Wegovy®, and Mounjaro® have been widely used for weight loss and metabolic health. Sublingual GLP-1 therapies, including Semaglutide and Tirzepatide, offer a needle-free alternative while delivering the same appetite-suppressing and metabolic benefits.

Like all medications, GLP-1 treatments can cause side effects. Common ones include nausea, diarrhea, and constipation, which are typically mild and decrease over time. Our clinical team will guide you through managing any side effects to ensure a smooth experience.

NAD+ injections help boost energy levels, improve fat metabolism, and enhance cellular function. They are an excellent complement to GLP-1 therapies, especially for those looking to maximize their metabolic health and weight loss results.

Our program includes:

• Online assessment with Dr. Terushkin
• Prescription for injectable or sublingual GLP-1 medication (Ozempic®, Wegovy®, Mounjaro®, Rybelsus®, Semaglutide, or Tirzepatide)
• Monthly medication reminders
• Ongoing clinical support and monitoring
• Guidance on diet and exercise to optimize your results

Results vary depending on individual factors, but many patients start seeing weight loss within the first few weeks of treatment. Over several months, significant and sustained weight loss is typically achieved, especially when combined with a healthy diet, physical activity, and additional metabolic support like NAD+ injections.